Return to homepagePandemic Pact

DualDIA - Dual electrochemical detection for rapid, on-site COVID-19 and host immune response diagnosis

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    Innovationsfonden Denmark

  • Principal Investigator

    N/A

  • Research Location

    Denmark

  • Lead Research Institution

    RUC, Lillebælt Hospital

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Until there is a vaccine against COVID-19, there is a need for a tool that can make it easier to sort and prioritize the many patients and thus help relieve the pressure on the healthcare system. The DualDIA project will develop a solution based on the biTEST diagnostic test. The test is based on an electrochemical examination procedure that can selectively and accurately detect both COVID-19 virus and antibodies as an expression of immunity. The underlying nanotechnology has previously been tested to diagnose severe bacterial infections, and now the project will test whether the method can be applied in the same way to COVID-19 patients.